A team of scientists analyzed data from over a dozen studies involving more than 900 people with MS to research iron rim ...

In a network meta-analysis of 25 randomized trials, sonelokimab was ranked highest for treating patients with moderate-to-severe hidradenitis suppurativa (HS). Adalimumab, lutikizumab, and ...